Free Consultation (800) 424-6690
Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | info@bergermontague.com

Newsroom Search

View all

featured news

February 12, 2026
Announcing Berger Montague’s New Trafficking and Forced Labor Practice
read more
February 12, 2026
Berger Montague PC Investigating Claims on Behalf of Investors in Kyndryl Holdings, Inc. (NYSE: KD) After Class Action Filing
read more
February 11, 2026
Berger Montague PC Investigating Claims on Behalf of Investors in uniQure N.V. (NASDAQ: QURE) After Class Action Filing
read more
April 4, 2014 General

Medicare Fraud Case Takes Aim at Unnecessary Prescriptions of Dangerous Drug Clozapine

In a case involving Teva Pharmaceuticals USA, LLC, the Department of Justice recently settled hundreds of allegations of Medicare and Medicaid fraud relating to the improper recommendation of the generic drug clozapine – considered a drug of last resort for the treatment of schizophrenia. According to allegations, Teva, through its […]
#clozapine #Healthcare Fraud #Medicaid Fraud #Medicare Fraud #Qui Tam #Whistleblower
$2.4B+
in 2025 post-trial judgments
$50B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated

On the Cutting Edge of the Profession

Legal Intelligencer